238 related articles for article (PubMed ID: 29940258)
1. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
2. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
3. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis.
Liu H; Dai Q; Li Y; Tang Z; She T
Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172
[TBL] [Abstract][Full Text] [Related]
4. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of galectins expression in patients with hepatic cancer: A meta-analysis.
Shao Q; He J; Chen Z; Wu C
Medicine (Baltimore); 2020 Apr; 99(15):e19622. PubMed ID: 32282710
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
Ramos-Martínez JC; Altamirano-Gómez G; Ramos-Martínez I; Valencia J; Hernández-Zimbrón L; Hernández-Juárez J; Echeverría-Vásquez P; Hernández-González LL; Pérez-Campos E; Pérez-Campos Mayoral L; Ramos-Martínez E
Clin Breast Cancer; 2022 Jul; 22(5):399-409. PubMed ID: 35058144
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of lncRNA PVT1 for Patients with Gastric Cancer: A Meta-Analysis.
Hao J; Yuan B; Gou Y; Ma J; Huang X
Dis Markers; 2021; 2021():5595965. PubMed ID: 34900027
[TBL] [Abstract][Full Text] [Related]
9. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis.
Wang C; Zhou X; Ma L; Zhuang Y; Wei Y; Zhang L; Jin S; Liang W; Shen X; Li C; Wang Y; Pang L
Pathol Res Pract; 2019 Oct; 215(10):152612. PubMed ID: 31474314
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Cho SJ; Kook MC; Lee JH; Shin JY; Park J; Bae YK; Choi IJ; Ryu KW; Kim YW
Int J Cancer; 2015 Feb; 136(4):810-20. PubMed ID: 24976296
[TBL] [Abstract][Full Text] [Related]
12. [Relationship Between Tim-3 and Galectin-9 Expression Levels, Clinical Pathological Characteristics, and Prognosis in Patients After Radical Resection of Colorectal Cancer].
Zhang Y; Deng D; Yin W; Luo J; Liu J; Xie C; Ji X; Ma L; Zhang L; Xia X; Cheng S; Huang A; Yang F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):375-382. PubMed ID: 38645842
[TBL] [Abstract][Full Text] [Related]
13. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
14. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer.
Jiang J; Jin MS; Kong F; Cao D; Ma HX; Jia Z; Wang YP; Suo J; Cao X
PLoS One; 2013; 8(12):e81799. PubMed ID: 24339967
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.
Chen J; Zhou SJ; Zhang Y; Zhang GQ; Zha TZ; Feng YZ; Zhang K
World J Gastroenterol; 2013 Apr; 19(13):2073-9. PubMed ID: 23599627
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
17. [Association of prognosis with insulin-like growth factor receptor type I expression in gastric cancer patients: a meta-analysis].
Gao Y; Cui J; Xi H; Shen W; Zhang K; Li J; Liang W; Hu C; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1051-5. PubMed ID: 26499155
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.
Ajani JA; Estrella JS; Chen Q; Correa AM; Ma L; Scott AW; Jin J; Liu B; Xie M; Sudo K; Shiozaki H; Badgwell B; Weston B; Lee JH; Bhutani MS; Onodera H; Suzuki K; Suzuki A; Ding S; Hofstetter WL; Johnson RL; Bresalier RS; Song S
Br J Cancer; 2018 Jan; 118(1):52-61. PubMed ID: 29136404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]